Drug Class
IL-23 inhibitor
Type
brand
Active Ingredient
risankizumab
📋Overview
Skyrizi is a medication that targets specific proteins involved in the body's immune response. It is commonly associated with the management of chronic inflammatory conditions, particularly those affecting the skin and joints. Skyrizi is often used in the context of diseases such as plaque psoriasis and psoriatic arthritis. Its action helps to reduce inflammation and related symptoms in these conditions.
📚References
Information from MedlinePlus.gov (NIH).
Found an Error?
Help us keep this information accurate. If you notice any incorrect details, please submit a correction request.
Find Discounts for Skyrizi
Hospitals.net Disclosure
Hospitals.net is an independent healthcare information platform and does not provide, administer, or guarantee prescription discounts, pricing, coupons, or pharmacy participation. All discount pricing and availability shown above are provided by RxGo and its partners and are subject to change without notice.
Hospitals.net may receive a commission or referral fee if you choose to use this prescription discount service. This does not affect the price you pay at the pharmacy. Hospitals.net is not responsible for pricing accuracy, pharmacy participation, or the fulfillment of any discount offers.